The invention relates to novel spirocyclic derivatives with affinity for Cav2.2 calcium channels and which are capable of interfering with Cav2.2 calcium channels; to processes for their preparation; to pharmaceutical compositions containing them; and to the use of such compounds in therapy for the treatment of pain.
SPIROCYCLIC DERIVATIVES WITH AFFINITY FOR CALCIUM CHANNELS
申请人:Convergence Pharmaceuticals Limited
公开号:EP2569317A1
公开(公告)日:2013-03-20
[EN] SPIROCYCLIC DERIVATIVES WITH AFFINITY FOR CALCIUM CHANNELS<br/>[FR] DÉRIVÉS SPIROCYCLIQUES PRÉSENTANT UNE AFFINITÉ POUR LES CANAUX CALCIQUES
申请人:CONVERGENCE PHARMACEUTICALS
公开号:WO2011141728A1
公开(公告)日:2011-11-17
The invention relates to novel spirocyclic derivatives with affinity for Cav2.2 calcium channels and which are capable of interfering with Cav2.2 calcium channels; to processes for their preparation; to pharmaceutical compositions containing them; and to the use of such compounds in therapy for the treatment of pain.